Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Kristen Ambrose

At a glance: Kristen Ambrose is Svp & Chief Accounting Officer at Vertex Pharmaceuticals (VRTX). Their latest SEC Form 4, filed Mar 2, 2026, reported a sale of $173K. On file: 0 purchase lines ($0) and 5 sale lines ($2.0M).

Disclosed holdings: about $3.5M of VRTX stock: 6,624 shares reported on their latest Form 4 (filed Mar 2, 2026), valued at the Nov 19, 2026 close of $521.30. This counts only VRTX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Svp & Chief Accounting Officer at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.0M

Kristen Ambrose's InsiderPrint

5 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Kristen Ambrose: 5 trades, 2026 to 20262026: 0 buys, 5 sales

Reading this print: Almost only sells, trading about 5 times a year, typically $302K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (5)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Prahlad R. SinghPlease See Remarks · RVTY · 100% match
  2. Barry BiffleCEO · ULCC · 100% match
  3. Emiliano KargiemanCEO · SATL · 100% match
  4. Sanjay KalraCFO · PAY · 100% match
  5. Matthew MoschnerCEO, President · CGNX · 100% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Mar 2SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 3576,624 held (−5%) $483.36 $173K +7.9%
Feb 26SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2236,981 held (−3%) $486.35 $108K +7.2%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,5578,388 held (−16%) $489.46 $762K +6.5%
Feb 19SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 6387,750 held (−8%) $473.68 $302K +10.1%
Feb 12SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,37610,127 held (−12%) $460.43 $634K +13.2%
  • Sell

    Svp & Chief Accounting Officer Kristen Ambrose sold $173K of VRTX at $483.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp & Chief Accounting Officer Kristen Ambrose sold $108K of VRTX at $486.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp & Chief Accounting Officer Kristen Ambrose sold $762K of VRTX at $489.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp & Chief Accounting Officer Kristen Ambrose sold $302K of VRTX at $473.68 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Svp & Chief Accounting Officer Kristen Ambrose sold $634K of VRTX at $460.43 — pre-scheduled 10b5-1 plan sale.

Follow Kristen Ambrose

Get one email when Kristen Ambrose files a new purchase or sale. Free.

At most one email a day about Kristen Ambrose, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.